Another study showed that activation of the LXR/ApoE axis in murine models reduced myeloid-derived suppressor cell (MDSC) populations, promoted cytotoxic T cell responses, and enhanced the efficacy of immunotherapies across multiple cancers [23], suggesting the immunomodulatory function of APOE. This evidence concerns the gene APOE and cancer.